A Peroxidase Peroxiredoxin 1-Specific Redox Regulation of the Novel FOXO3 microRNA Target let-7
暂无分享,去创建一个
Da Yang | M. Nadler | S. Oesterreich | K. Ndebele | M. Rizzo | R. Khosravi‐Far | T. Bertomeu | D. Datta | C. Neumann | Barbara L. Hopkins | J. Skoko | A. Pelosi | B. Pennarun | O. Bucur | Bo Yang | K. Levine | Parisa Mousavi Shafaei | Anja Schempf | Bodvael Pennarun | Octavian Bucur
[1] M. Santoro,et al. ROS homeostasis and metabolism: a dangerous liason in cancer cells , 2016, Cell Death and Disease.
[2] Michael J. Davies,et al. Protein oxidation and peroxidation , 2016, The Biochemical journal.
[3] Andrew D. Sharrocks,et al. Genome-wide binding studies reveal DNA binding specificity mechanisms and functional interplay amongst Forkhead transcription factors , 2015, Nucleic acids research.
[4] Andrea Bild,et al. Alternative preprocessing of RNA-Sequencing data in The Cancer Genome Atlas leads to improved analysis results , 2015, Bioinform..
[5] Weiwen Shen,et al. Overexpression of Prdx1 in hilar cholangiocarcinoma: a predictor for recurrence and prognosis. , 2015, International journal of clinical and experimental pathology.
[6] A. Rustgi,et al. Let-7 Represses Carcinogenesis and a Stem Cell Phenotype in the Intestine via Regulation of Hmga2 , 2015, PLoS genetics.
[7] B. Snel,et al. Evolutionary acquisition of cysteines determines FOXO paralog-specific redox signaling. , 2015, Antioxidants & redox signaling.
[8] Michael J. Oehler,et al. Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling. , 2015, Nature chemical biology.
[9] E. Garrett-Mayer,et al. Regulation of the Tumor Suppressor FOXO3 by the Thromboxane-A2 Receptors in Urothelial Cancer , 2014, PloS one.
[10] Hong Jiang,et al. Expression of peroxiredoxin 1 and 4 promotes human lung cancer malignancy. , 2014, American journal of cancer research.
[11] H. Taylor,et al. Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation , 2014, Oncogene.
[12] M. Putker,et al. Intermolecular disulfide-dependent redox signalling. , 2014, Biochemical Society transactions.
[13] G. Kundu,et al. Semaphorin 3A upregulates FOXO 3a-dependent MelCAM expression leading to attenuation of breast tumor growth and angiogenesis , 2014, Oncogene.
[14] K. Naka,et al. Crosstalk between the Rb pathway and AKT signaling forms a quiescence-senescence switch. , 2014, Cell reports.
[15] H. Stunnenberg,et al. Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors , 2014, Molecular Cancer Research.
[16] V. Nizet,et al. Transcription Factor Binding Site Analysis Identifies FOXO Transcription Factors as Regulators of the Cutaneous Wound Healing Process , 2014, PloS one.
[17] Hong-zhao Li,et al. Downregulation of FOXO3a Promotes Tumor Metastasis and Is Associated with Metastasis-Free Survival of Patients with Clear Cell Renal Cell Carcinoma , 2014, Clinical Cancer Research.
[18] Shaolei Li,et al. MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3. , 2014, Cancer letters.
[19] Y. Liu,et al. Role for Prdx1 as a specific sensor in redox-regulated senescence in breast cancer , 2013, Oncogene.
[20] Marilena V. Iorio,et al. MicroRNAs and Triple Negative Breast Cancer , 2013, International journal of molecular sciences.
[21] S. Andò,et al. The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness , 2013, Cell cycle.
[22] C. Winterbourn,et al. Hyperoxidized peroxiredoxin 2 interacts with the protein disulfide- isomerase ERp46. , 2013, The Biochemical journal.
[23] Jinyi Guo,et al. The Heterochronic microRNA let-7 Inhibits Cell Motility by Regulating the Genes in the Actin Cytoskeleton Pathway in Breast Cancer , 2013, Molecular Cancer Research.
[24] A. Eijkelenboom,et al. FOXOs: signalling integrators for homeostasis maintenance , 2013, Nature reviews. Molecular cell biology.
[25] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .
[26] Wei Wang,et al. Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma , 2013, Medical Oncology.
[27] Aamir Ahmad,et al. The Role of MicroRNAs in Breast Cancer Migration, Invasion and Metastasis , 2012, International journal of molecular sciences.
[28] S. Hughes,et al. Peroxiredoxin 1 functions as a signal peroxidase to receive, transduce, and transmit peroxide signals in mammalian cells. , 2012, Free radical biology & medicine.
[29] R. Gregory,et al. How does Lin28 let-7 control development and disease? , 2012, Trends in cell biology.
[30] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[31] Ning Liu,et al. Regulation of let-7 and its target oncogenes (Review). , 2012, Oncology letters.
[32] Smita Misra,et al. High Motility of Triple-negative Breast Cancer Cells Is Due to Repression of Plakoglobin Gene by Metastasis Modulator Protein SLUG* , 2012, The Journal of Biological Chemistry.
[33] M. Ringnér,et al. The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transition , 2012, Breast Cancer Research.
[34] In Sup Kil,et al. Peroxiredoxin Functions as a Peroxidase and a Regulator and Sensor of Local Peroxides* , 2011, The Journal of Biological Chemistry.
[35] Lara J. Monteiro,et al. Phosphorylation of FOXO3a on Ser-7 by p38 Promotes Its Nuclear Localization in Response to Doxorubicin* , 2011, The Journal of Biological Chemistry.
[36] N. Hay,et al. PI3K-AKT-FoxO axis in cancer and aging. , 2011, Biochimica et biophysica acta.
[37] James B. Mitchell,et al. Cellular Stress Induced Alterations in MicroRNA let-7a and let-7b Expression Are Dependent on p53 , 2011, PloS one.
[38] Y. Funato,et al. Oligomeric peroxiredoxin-I is an essential intermediate for p53 to activate MST1 kinase and apoptosis , 2011, Oncogene.
[39] B. Burgering,et al. Forkhead box o as a sensor, mediator, and regulator of redox signaling. , 2011, Antioxidants & redox signaling.
[40] M. Monsalve,et al. Inactivation of Foxo3a and Subsequent Downregulation of PGC-1α Mediate Nitric Oxide-Induced Endothelial Cell Migration , 2010, Molecular and Cellular Biology.
[41] W. Hahn,et al. Protein Phosphatase 2A Reactivates FOXO3a through a Dynamic Interplay with 14-3-3 and AKT , 2010, Molecular biology of the cell.
[42] Sun-Mi Park,et al. The role of let-7 in cell differentiation and cancer. , 2010, Endocrine-related cancer.
[43] P. Storz,et al. Reactive oxygen species in cancer , 2010, Free radical research.
[44] W. Freeman,et al. FOXO3a elicits a pro-apoptotic transcription program and cellular response to human lung carcinogen nicotine-derived nitrosaminoketone (NNK). , 2010, Lung cancer.
[45] Z. Szallasi,et al. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients , 2010, Breast Cancer Research and Treatment.
[46] C. Neumann,et al. Peroxiredoxin 1 and its role in cell signaling , 2009, Cell cycle.
[47] Anne-Sophie Coldefy,et al. Regulation of the Intracellular Localization of Foxo3a by Stress-Activated Protein Kinase Signaling Pathways in Skeletal Muscle Cells , 2009, Molecular and Cellular Biology.
[48] M. Gutscher,et al. Proximity-based Protein Thiol Oxidation by H2O2-scavenging Peroxidases*♦ , 2009, The Journal of Biological Chemistry.
[49] M. G. Koerkamp,et al. Redox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity. , 2009, Nature chemical biology.
[50] James B. Mitchell,et al. Ionizing Radiation-Induced Oxidative Stress Alters miRNA Expression , 2009, PloS one.
[51] P. Karplus,et al. Typical 2‐Cys peroxiredoxins – structures, mechanisms and functions , 2009, The FEBS journal.
[52] N. Leslie,et al. Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity , 2009, The EMBO journal.
[53] So Yong Kim,et al. A novel function of peroxiredoxin 1 (Prx‐1) in apoptosis signal‐regulating kinase 1 (ASK1)‐mediated signaling pathway , 2008, FEBS letters.
[54] D. Tindall,et al. FOXOs, cancer and regulation of apoptosis , 2008, Oncogene.
[55] A. Brunet,et al. The FoxO code , 2008, Oncogene.
[56] Roya Khosravi-Far,et al. FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis. , 2008, Biochimica et biophysica acta.
[57] P. Yelick,et al. The pro‐apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1 , 2007, The EMBO journal.
[58] Quan Fang,et al. Are peroxiredoxins tumor suppressors? , 2007, Current opinion in pharmacology.
[59] G. Sonenshein,et al. Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells. , 2007, Cancer research.
[60] B. Burgering,et al. Stressing the role of FoxO proteins in lifespan and disease , 2007, Nature Reviews Molecular Cell Biology.
[61] Yonghong Xiao,et al. FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell Homeostasis , 2007, Cell.
[62] S. Rhee,et al. H2O2, a Necessary Evil for Cell Signaling , 2006, Science.
[63] Judit Villén,et al. A Conserved MST-FOXO Signaling Pathway Mediates Oxidative-Stress Responses and Extends Life Span , 2006, Cell.
[64] S. Rhee. Cell signaling. H2O2, a necessary evil for cell signaling. , 2006, Science.
[65] Ryuji Kobayashi,et al. IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a , 2004, Cell.
[66] Ryuji Kobayashi,et al. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. , 2004, Cell.
[67] S. Orkin,et al. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression , 2003, Nature.
[68] P. Cohen,et al. Two novel phosphorylation sites on FKHR that are critical for its nuclear exclusion , 2002, The EMBO journal.
[69] M. Greenberg,et al. Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.